background
lower
respiratori
tract
infect
lrti
lead
caus
childhood
morbid
mortal
potenti
pathogen
organ
present
respiratori
tract
symptomat
asymptomat
children
presenc
necessarili
indic
diseas
aim
assess
concord
upper
lower
respiratori
tract
microbiota
lrti
use
nasopharyng
microbiota
discrimin
lrti
health
method
first
prospect
studi
children
age
week
year
admit
paediatr
intens
care
unit
picu
wilhelmina
children
hospit
utrecht
netherland
whodefin
lrti
requir
mechan
ventil
obtain
pair
nasopharyng
swab
deep
endotrach
aspir
particip
socal
picu
cohort
sept
sept
also
match
casecontrol
studi
inclus
criteria
children
lrti
three
dutch
teach
hospit
agematch
sexmatch
timematch
healthi
children
recruit
commun
nasopharyng
sampl
obtain
admiss
case
home
visit
control
data
child
characterist
obtain
questionnair
pharmaci
printout
medic
chart
use
quantit
pcr
rrnabas
sequenc
establish
viral
bacteri
microbiota
profil
respect
spars
random
forest
classifi
analys
bacteri
data
viral
data
metadata
combin
three
dataset
distinguish
case
control
iqr
p
taxa
high
nasopharyng
endotrach
aspir
sampl
support
use
nasopharyng
sampl
proxi
lung
microbiota
lrti
case
match
control
prospect
recruit
casecontrol
cohort
individu
bacteri
microbiota
area
curv
viral
microbiota
child
characterist
poorli
distinguish
health
diseas
howev
classif
model
base
combin
bacteri
viral
microbiota
plu
child
characterist
distinguish
children
lrti
match
control
high
degre
accuraci
area
curv
interpret
data
suggest
nasopharyng
microbiota
serv
valid
proxi
lower
respiratori
tract
microbiota
childhood
lrti
clinic
lrti
children
result
interplay
microbiota
host
characterist
rather
singl
microorgan
microbiotabas
diagnost
could
improv
futur
diagnost
treatment
protocol
lower
respiratori
tract
infect
lrti
major
caus
morbid
mortal
children
world
wide
although
multipl
host
environment
lifestyl
factor
known
increas
suscept
lrti
children
remain
asymptomat
exposur
pathogen
other
develop
sever
diseas
remain
unclear
classic
lrti
caus
acquisit
upper
respiratori
tract
pathogen
virus
bacteria
replic
spread
toward
lower
respiratori
tract
invad
mucosa
lead
inflamm
clinic
diseas
mani
microorgan
howev
pathobiont
frequent
encount
upper
respiratori
tract
healthi
children
therefor
hypothesis
balanc
microbi
commun
protect
patho
biont
caus
lrti
previou
studi
children
shown
relat
bacteri
composit
nasopharynx
micro
biota
suscept
upper
lower
respiratori
infecti
episod
time
report
oral
microb
prevotella
leptotrichia
spp
nasopharyng
nich
strongli
associ
subsequ
develop
upper
respiratori
tract
infect
children
abund
infect
contrast
corynebacterium
dolosigranulum
spp
associ
resist
symptomat
respiratori
diseas
first
year
life
less
abund
upper
respiratori
tract
infect
addit
infant
lrti
caus
respiratori
syncyti
viru
increas
presenc
haemophilu
influenza
streptococcu
pneumonia
strongli
associ
increas
sever
host
inflamm
suggest
import
role
complet
microbiota
upper
respiratori
tract
symptomolog
clinic
diseas
casecontrol
studi
yet
address
relat
nasopharyng
microbiota
presenc
clinic
symptom
sever
childhood
lrti
furthermor
profil
nasopharyng
microbiota
never
studi
context
classif
state
health
diseas
aim
investig
associ
upper
lower
respiratori
tract
microbiota
childhood
lrti
use
microbiota
predict
presenc
sever
lrti
associ
microbiota
diseas
across
differ
clinic
present
lrti
prospect
strictli
match
casecontrol
studi
young
children
hospitalis
lrti
first
prospect
studi
sept
sept
assess
whether
acut
paediatr
lrti
nasopharynx
microbiota
serv
valid
proxi
lower
respiratori
tract
microbiota
elig
children
age
week
year
admit
paediatr
intens
care
unit
picu
wilhelmina
children
hospit
utrecht
netherland
whodefin
lrti
requir
mechan
ventil
refer
group
picu
cohort
appendix
exclus
criteria
detail
appendix
period
also
prospect
match
casecontrol
studi
inclus
exclus
criteria
use
picu
cohort
case
recruit
three
dutch
teach
hospit
spaarn
hospit
hoofddorp
kennem
gasthui
haarlem
st
antoniu
hospit
nieuwegein
case
two
agematch
sexmatch
timematch
healthi
control
recruit
pool
healthi
children
age
year
recruit
wellbabi
clinic
local
municip
appendix
healthi
child
seem
proper
match
new
case
articl
publish
languag
may
identifi
public
three
pertain
role
microbiota
acut
lrti
children
one
studi
focus
infant
high
risk
atopi
show
specif
microbiota
profil
associ
develop
respiratori
infect
second
small
match
casecontrol
studi
show
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
associ
case
wherea
specif
taxon
associ
control
howev
studi
underpow
provid
conclus
result
third
studi
includ
infant
younger
year
includ
control
group
healthi
children
show
moraxella
associ
less
sever
bronchiol
streptococcu
associ
sever
bronchiol
studi
show
nasopharyng
viral
bacteri
microbiota
use
proxi
lung
microbiota
childhood
lrti
also
show
relationship
microbi
commun
composit
suscept
sever
lrti
children
use
strictli
match
casecontrol
design
cohort
children
studi
first
confid
show
associ
microbiota
lrti
children
knowledg
accuraci
model
develop
discrimin
lrti
health
unpreced
furthermor
phenotypeindepend
natur
associ
respiratori
microbiota
childhood
lrti
previous
report
complet
nasopharyng
ecosystem
import
role
develop
sever
lrti
young
children
excel
accuraci
classifi
model
provid
basi
futur
microbiotabas
diagnost
tool
could
major
implic
futur
treatment
protocol
data
provid
insight
could
crucial
establish
optim
therapeut
strategi
includ
target
antibiot
treatment
phenotypeindepend
associ
acut
diseas
identifi
challeng
convent
view
role
virus
bacteria
lrti
pathogenesi
especi
dichotomi
bronchiol
viral
origin
pneumonia
bacteri
origin
see
onlin
appendix
contact
visit
home
within
week
admiss
case
studi
approv
dutch
nation
ethic
committe
casecontrol
studi
conform
strengthen
report
observ
studi
epidemiolog
strobe
guidelin
report
casecontrol
studi
appendix
written
inform
consent
obtain
parent
particip
detail
studi
appendix
picu
cohort
nasopharyng
swab
endotrach
aspir
obtain
within
h
intub
train
nurs
casecontrol
studi
nasopharyng
swab
taken
case
gener
within
h
admiss
paediatr
ward
home
visit
control
extens
medic
histori
taken
demograph
lifestyl
environment
data
collect
children
studi
two
expert
paediatrician
mavh
mem
independ
classifi
case
casecontrol
studi
one
three
major
diseas
phenotyp
pneumonia
bronchiol
wheez
ill
case
unclear
phenotyp
classifi
mix
disagr
paediatrician
solv
consensu
classif
base
entir
medic
record
includ
clinic
note
admiss
result
laboratori
assess
imag
done
bacteri
dna
isol
sampl
previous
describ
amplif
hypervari
region
rrna
gene
done
barcod
univers
primer
pair
amplicon
pool
sequenc
illumina
miseq
platform
san
diego
ca
usa
process
bioinformat
pipelin
previous
describ
avoid
oper
taxonom
unit
otu
ident
annot
refer
otu
taxonom
annot
combin
rank
number
base
abund
one
case
otu
could
confid
annot
either
two
speci
speci
indic
separ
solidu
virus
genet
profil
qualit
multiplex
realtim
pcr
respifind
smartfast
maastricht
netherland
pneumonia
staphylococcu
aureu
h
influenza
moraxella
catar
rhali
identifi
quantit
pcr
analys
match
sampl
account
match
natur
sampl
p
valu
less
benjaminihochberg
adjust
q
valu
less
consid
signific
signific
differ
baselin
characterist
viral
detect
calcul
condit
logist
regress
nonmetr
multidimension
scale
plot
base
braycurti
dissimilar
matric
signific
calcul
adoni
vegan
assess
concord
bacteri
microbiota
composit
nasopharynx
endotrach
aspir
compar
intraindividu
interindividu
braycurti
similar
calcul
braycurti
dissimilar
statist
signific
establish
wilcoxon
ranksum
test
correl
individu
bacteri
taxa
pair
sampl
determin
pearson
correl
assess
host
characterist
associ
microbiota
composit
stepwis
select
distancebas
redund
analysi
project
nonmetr
multidimension
scale
plot
use
envfit
vegan
hierarch
cluster
describ
previous
random
forest
analys
use
establish
biomark
speci
discrimin
cluster
vsurf
use
metagenomeseq
crossvalid
vsurf
analys
identifi
specif
microbi
taxa
associ
case
control
spars
random
forest
classifi
analys
done
bacteri
data
viral
data
metadata
combin
three
dataset
assess
perform
classifi
calcul
area
receiv
oper
characterist
curv
outofbag
predict
classif
previous
describ
potenti
realworld
applic
classif
model
requir
robust
determin
biomark
bacteria
also
built
classif
model
otu
merg
genu
level
analys
done
entir
casecontrol
cohort
repeat
part
phenotyp
independ
built
crossvalid
spars
random
forest
predict
model
investig
extent
durat
hospitalis
measur
diseas
sever
could
predict
avail
data
caret
second
measur
diseas
sever
stratifi
case
accord
physician
decis
treat
antibiot
admiss
dutch
paediatrician
gener
reserv
antibiot
treatment
children
clinic
sever
lrti
separ
posthoc
analys
accordingli
third
measur
sever
posthoc
analysi
nasopharyng
data
picu
cohort
relat
agematch
seasonmatch
subset
casecontrol
cohort
data
analys
done
r
version
studi
funder
role
studi
design
data
collect
analysi
interpret
write
report
correspond
author
full
access
studi
data
final
respons
decis
submit
public
patient
enrol
picu
cohort
viral
presenc
pair
nasopharyng
endotrach
aspir
almost
full
agreement
ci
bacteri
microbiota
pair
sampl
show
good
concord
composit
median
within
braycurti
similar
low
interparticip
concord
p
appendix
furthermor
note
significantli
correl
shannon
divers
pearson
r
p
taxa
combin
rel
abund
strongli
correl
pair
sampl
median
pearson
r
iqr
p
taxa
individu
three
common
constitu
nasopharyng
microbiotastaphylococcu
corynebacterium
dolosigranulum
sppwere
almost
exclus
present
nasopharyng
sampl
absent
endotrach
aspir
pearson
r
three
p
three
individu
appendix
identifi
taxa
endotrach
sampl
present
nasopharynx
sampl
appendix
assess
whether
differ
rel
abund
individu
taxa
nasopharyng
sampl
endotrach
aspir
found
signific
result
corynebacterium
propinquum
kruskalw
test
benjaminihochberg
adjust
corynebacterium
macginleyiaccolen
dolosigranulum
pigrum
three
low
abund
taxa
median
rel
abund
peopl
picu
cohort
suspect
bacteri
infect
cultureconfirm
bacteri
infect
nine
suspect
viral
infect
five
receiv
antibiot
treatment
sampl
differ
overal
microbiota
composit
picu
cohort
without
bacteri
infect
receiv
antibiot
sampl
appendix
furthermor
stratifi
analysi
show
differ
subcohort
result
concord
analys
appendix
recruit
case
control
one
case
one
match
healthi
control
could
recruit
databas
tabl
casecontrol
studi
case
control
femal
tabl
median
age
case
month
iqr
case
significantli
like
histori
respiratori
tract
infect
wheez
symptom
use
antibiot
past
month
expos
tobacco
smoke
control
tabl
control
breastf
least
month
often
case
educ
level
parent
control
higher
case
tabl
control
cohort
composit
respiratori
microbiota
significantli
associ
month
sampl
age
daycar
attend
breastfeed
parentreport
histori
respiratori
tract
infect
particip
previou
antibiot
treatment
within
past
month
among
other
p
appendix
sex
correl
microbiota
composit
control
cohort
viral
data
avail
case
control
appendix
detect
one
virus
case
control
p
figur
mean
virus
per
case
sampl
per
control
sampl
commonli
detect
virus
overal
rhinoviru
coronavirus
respiratori
syncyti
viru
adenovirus
figur
influenza
rel
rare
group
figur
data
n
median
iqr
data
medic
use
acquir
pharmaci
printout
wherea
rest
data
acquir
parent
questionnair
match
factor
test
calcul
univari
condit
logist
regress
parentreport
lower
respiratori
tract
infect
exclus
level
class
low
primari
school
educ
prevoc
educ
highest
qualif
intermedi
select
secondari
educ
vocat
educ
high
degre
univers
appli
scienc
academ
univers
significantli
associ
health
test
p
appendix
posteriori
plot
biomark
speci
cluster
nonmetr
multi
dimension
scale
ordin
support
associ
profil
health
diseas
figur
profil
domin
h
influenzaehaemolyticu
median
bacteri
load
appendix
significantli
higher
bacteri
load
profil
wilcoxon
ranksum
test
p
comparison
except
domin
aureusepidermidi
median
bacteri
load
spneumoniaedomin
profil
significantli
higher
profil
domin
c
propinquum
pigrum
differ
profil
domin
catarrhalisnonliquefacien
individu
bacteri
taxon
level
taxa
differenti
case
control
combin
rel
abund
betweengroup
differ
confirm
bacteria
crossvalid
random
forest
analysi
appendix
among
differenti
abund
taxa
note
significantli
higher
abund
h
influenzaeh
haemolyticu
pneumonia
actinomyc
spp
prevotella
spp
lrti
case
control
significantli
higher
abund
differ
moraxella
spp
c
propinquum
pigrum
helcococcu
spp
control
case
appendix
mavh
mem
classifi
case
pneumonia
bronchiol
wheez
ill
case
mix
appendix
respiratori
syncyti
viru
common
case
bronchiol
stratifi
clinic
phenotyp
overal
bacteri
microbiota
composit
differ
significantli
case
control
present
appendix
differenti
abund
individu
microb
case
control
highli
similar
phenotyp
appendix
phenotyp
haemophilu
neisseria
oral
taxa
eg
actinomyc
overrepres
multipl
moraxella
dolosigranulum
helcococcu
spp
underrepres
case
compar
control
appendix
differ
microbiota
composit
case
control
mixedphenotyp
group
larg
overlap
three
phenotyp
appendix
combin
viral
bacteri
biomark
host
factor
spars
random
forest
analysi
accuraci
classif
lrti
versu
health
high
area
curv
auc
figur
import
predictor
diseas
among
other
presenc
respiratori
syncyti
viru
high
abund
h
influenzaehaemolyticu
pneumonia
pseudomona
fluorescen
low
abund
sever
moraxella
spp
antibiot
treatment
past
month
lack
breastfeed
figur
combin
classif
system
outperform
model
base
bacteri
microbiota
alon
auc
viral
microbiota
alon
child
characterist
alon
model
two
classic
import
pathobiontsi
respiratori
syncyti
viru
pneumoniaewer
includ
auc
extern
valid
classifi
model
picu
cohort
show
correct
classif
nasopharyng
sampl
endotrach
aspir
separ
model
phenotyp
show
equal
high
accuraci
classif
lrti
auc
figur
cf
test
broad
univers
applic
classif
model
bacteri
microbiota
data
cluster
genu
level
instead
otu
level
classif
presenc
lrti
versu
health
high
entir
cohort
auc
phenotypespecif
auc
appendix
physician
prescrib
antibiot
treatment
sampl
nasopharynx
case
pneumonia
case
four
bronchiol
case
four
case
wheez
ill
six
case
mix
infect
posthoc
analys
viral
presenc
microbiota
admiss
differ
infant
prescrib
antibiot
prescrib
antibiot
appendix
respect
bacteri
ecolog
note
similar
slightli
pronounc
differ
microbiota
composit
children
prescrib
antibiot
match
control
p
prescrib
antibiot
match
control
p
appendix
children
prescrib
antibiot
increas
abund
pathobiont
h
influenzaehaemolyticu
pneumonia
increas
abund
oral
taxa
veillonella
prevotella
actinomyc
spp
appendix
durat
hospitalis
could
predict
fairli
accur
use
data
avail
admiss
random
forest
model
includ
viral
bacteri
host
characterist
pearson
r
p
appendix
predictor
highest
lowest
import
younger
age
abund
c
propinquum
neisseria
aureusepidermidi
appendix
children
prescrib
antibiot
includ
predict
hospitalis
durat
admiss
becam
stronger
pearson
r
p
wherea
predict
abil
lost
prescrib
antibiot
includ
appendix
overal
microbiota
composit
picu
case
substanti
differ
healthi
control
p
case
casecontrol
cohort
p
appendix
furthermor
picu
case
pronounc
overrepresent
sever
haemophilu
streptococcu
includ
pneumonia
veillonella
actinomyc
spp
pronounc
underrepresent
multipl
moraxella
spp
especi
dolosigranulum
corynebacterium
spp
case
compar
healthi
control
appendix
match
casecontrol
studi
show
strong
associ
upper
respiratori
tract
microbiota
presenc
sever
childhood
lrti
also
show
lrti
uniqu
differenti
health
combin
viral
bacteri
lifestyl
environment
predictor
underlin
multifactori
pathophysiolog
childhood
lrti
furthermor
show
predict
abil
larg
independ
clinic
phenotyp
upper
respiratori
tract
microbiom
gener
thought
sourc
lrti
childhood
show
nine
bacteri
speci
biomark
determin
random
forest
analysi
hierarch
cluster
result
wherea
b
show
posteriori
project
covari
significantli
explain
composit
variat
case
control
grey
repres
signific
univari
analysi
black
signific
multivari
analysi
associ
age
purpl
ellips
repres
sd
point
within
cohort
oper
taxonom
unit
bacteri
speci
refer
taxonom
annot
rank
number
shown
parenthes
base
abund
given
oper
taxonom
unit
readabl
select
covari
explain
largest
variat
case
control
display
b
b
age
effect
vertic
orient
younger
vs
older
particip
roughli
perpendicular
diseasehealth
axi
horizont
orient
show
agerel
differ
microbiota
composit
per
se
associ
diseas
nmdsnonmetr
multidimension
scale
lrtislow
respiratori
tract
infect
time
sampl
particip
least
one
famili
member
experienc
respiratori
tract
infect
corynebacterium
propinquum
corynebacterium
macginleyiaccolen
staphylococcu
aureu
epidermidi
actinobacillu
porcinu
veillonella
dispar
micro
biota
profil
nasopharyng
endotrach
aspir
sampl
patient
lrti
admit
picu
braycurti
similar
approxim
biolog
replic
ie
two
sequenti
obtain
lavag
lung
lobe
child
microbiota
profil
lung
find
suggest
upper
associ
diseas
associ
health
respiratori
microbiota
sourc
lower
respiratori
tract
also
except
commens
speci
microbi
colonis
prolifer
nasopharynx
parallel
lower
airway
childhood
lrti
therefor
find
support
idea
upper
respiratori
tract
sampl
use
proxi
lung
microbiota
childhood
lrti
next
unselect
strictli
match
casecontrol
cohort
show
strong
associ
nasopharyng
microbiota
composit
presenc
childhood
lrti
viral
presenc
ubiquit
case
control
respiratori
syncyti
viru
lesser
extent
human
metapneumoviru
highli
overrepres
case
line
result
studi
viral
caus
childhood
lrti
presenc
abund
haemophilu
spp
pneumonia
oral
speci
strongli
associ
diseas
line
previou
report
link
taxa
suscept
sever
respiratori
tract
infect
children
contrast
abund
potenti
benefici
bacteria
like
moraxella
corynebacterium
dolosigranulum
helcococcu
spp
underrepres
case
line
previou
report
connect
genera
prevent
infect
combin
viral
bacteri
hostrel
predictor
abl
differenti
children
lrti
strictli
match
healthi
control
accuraci
predict
infect
greatli
diminish
individu
predictor
use
underlin
multifactori
pathophysiolog
childhood
lrti
contribut
nasopharyng
microbiota
bacteri
viral
seem
larg
independ
clinic
present
even
hold
bronchiol
wheez
ill
gener
assum
viral
caus
result
casecontrol
studi
confirm
independ
second
cohort
show
corynebacterium
dolosigranulum
nearli
absent
children
lrti
admit
picu
suggest
children
especi
reduc
resist
overgrowth
dissemin
pathobiont
lung
furthermor
posthoc
analys
oral
speci
associ
decis
treat
antibiot
durat
hospitalis
suggest
abund
speci
associ
sever
lrti
possibl
mechan
gramneg
oral
bacteria
promot
proinflammatori
mucos
respons
lead
increas
catecho
lamin
turn
acceler
growth
gramneg
oral
speci
potenti
pathogen
haemophilu
spp
pneumonia
therefor
would
interest
studi
whether
prescrib
antibiot
basi
abund
oral
bacteria
respiratori
specimen
would
improv
outcom
find
three
implic
first
accuraci
model
discrimin
lrti
health
suggest
microbiotabas
diagnost
might
potenti
clinic
applic
diagnost
detect
potenti
pathogen
virus
bacteria
cover
pathobiont
discrimin
poorli
asymptomat
colonis
caus
symptomat
diseas
microbiotabas
diagnost
classif
tool
could
improv
accuraci
discriminatori
power
would
major
implic
treatment
protocol
proofofprincipl
studi
rapid
microbiotabas
diagnosi
h
sever
pneumonia
adult
show
diagnost
tool
improv
diagnost
accuraci
could
clinic
appli
cost
technolog
decreas
becom
avail
paediatr
use
use
broadspectrum
antibiot
could
avoid
often
abund
overgrow
speci
could
target
narrowspectrum
drug
although
microbiotabas
approach
valid
independ
cohort
similar
perform
genuslevel
model
suggest
potenti
futur
develop
univers
countrybas
regionbas
model
predict
sever
durat
diseas
combin
microbiota
host
charact
istic
model
would
potenti
allow
physician
increas
decreas
threshold
antimicrobi
treatment
depend
predict
outcom
second
find
specif
group
microorgan
associ
health
line
data
studi
around
world
suggest
studi
done
obtain
mechanist
insight
potenti
role
speci
diseas
prevent
corynebacterium
spp
report
reduc
virul
aureu
inhibit
growth
pneumonia
vitro
furthermor
nasal
applic
coryn
bacterium
spp
induc
resist
respiratori
syncyti
viru
secondari
pneumococc
pneumonia
infant
mice
find
emphasis
need
futur
research
effort
assess
combin
effect
commens
bacteria
modul
respiratori
ecosystem
especi
contain
potenti
pathogen
respiratori
syncyti
viru
haemophilu
spp
streptococcu
spp
host
immun
respons
underli
respiratori
symptom
third
phenotypeindepend
associ
viral
bacteri
microbiota
lrti
parallel
highli
overlap
clinic
present
diseas
children
mean
robust
gold
standard
accur
classif
treatment
lrti
avail
find
contribut
emerg
bodi
evid
suggest
virus
contribut
presum
bacteri
pneumonia
bacteria
seem
import
role
pathogenesi
sever
presum
viral
bronchiol
wheez
ill
find
show
inappropri
convent
singlebacteria
singleviru
causat
per
koch
postul
find
also
allud
hypothesi
univers
pathway
develop
clinic
lrti
link
microbi
dysbiosi
wherebi
clinic
pheno
type
driven
host
eg
age
anatomi
baselin
mucos
inflamm
statu
innat
adapt
immun
genet
background
environ
mental
characterist
rather
singl
pathogen
characterist
thu
treatment
decis
base
clinic
phenotyp
rather
diseas
sever
scientif
debat
begin
addit
confirmatori
studi
result
mani
discuss
among
clinician
microbiologist
biologist
need
take
place
howev
diagnost
treatment
protocol
could
adapt
within
next
year
chang
judg
appropri
major
strength
studi
strictli
match
casecontrol
design
preclud
bia
result
confound
effect
age
time
sex
furthermor
unselect
recruit
case
given
us
cohort
highli
repres
patient
treat
paediatr
clinician
consist
pattern
unsupervis
ie
hierarch
cluster
supervis
ie
metagenomeseq
analys
contribut
robust
result
studi
also
limit
first
casecontrol
design
could
theoret
introduc
select
bia
could
affect
valid
reproduc
result
second
quantit
pcrbase
assay
detect
known
respiratori
virus
rather
entir
respiratori
virom
howev
virom
studi
report
high
concord
result
metagenom
sequenc
quantit
pcrbase
assay
third
observ
studi
find
necessarili
prove
causal
longitudin
analys
underway
address
causal
respiratori
microbiota
respiratori
diseas
fourth
endotrach
aspir
might
perfectli
reflect
lower
respiratori
tract
microbiota
extend
bronchi
alveoli
said
clinic
evid
base
convent
microbiolog
data
suggest
tracheal
aspir
good
proxi
lower
respiratori
tract
therefor
appropri
proxi
clinic
diagnosi
caus
diseas
children
sever
lrti
furthermor
data
publish
show
strong
concord
neglig
differ
bacteri
microbiota
endotrach
sampl
bronchial
lavag
final
rrna
sequenc
permit
annot
genuslevel
specieslevel
identif
bacteria
provid
resolut
metagenom
techniqu
eg
shotgun
sequenc
especi
close
relat
speci
streptococc
speci
tri
provid
specieslevel
data
use
quantit
pcr
confirm
four
common
potenti
pathogen
otu
find
support
conclus
howev
futur
studi
might
need
multipl
level
confirm
data
refin
conclus
overal
find
suggest
microbiotabas
diagnost
explor
addit
predict
model
sever
diseas
valid
differ
set
countri
explor
use
treatment
optimis
antimicrobi
stewardship
mavh
eam
db
conceiv
design
studi
whm
mavh
mem
amv
njgj
enrol
particip
mljnc
respons
execut
qualiti
control
laboratori
work
whm
db
analys
data
whm
mavh
eam
db
wrote
paper
author
interpret
result
critic
revis
articl
import
intellectu
content
approv
final
version
eam
receiv
unrestrict
research
support
pfizer
grant
support
vaccin
studi
pfizer
glaxosmithklin
db
receiv
unrestrict
fee
paid
institut
advisori
work
friesland
campina
research
support
nutricia
medimmun
author
report
compet
interest
sequenc
data
support
find
studi
deposit
us
nation
center
biotechnolog
inform
sequenc
read
archiv
databas
bioproject
id
